pimagedine has been researched along with alt-946 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kawakami, M; Kuroki, M | 1 |
Cooper, ME; Davis, B; Jaworski, K; Kelly, DJ; Koerner, SM; Thallas, V; Wilkinson-Berka, JL | 1 |
Ishikawa, N; Kurokawa, K; Miyata, T | 1 |
Bolton, WK; Turgut, F | 1 |
3 review(s) available for pimagedine and alt-946
Article | Year |
---|---|
[Aminoguanidine and other AGE inhibitors].
Topics: Amides; Animals; Arteriosclerosis; Cardiovascular Diseases; Cataract; Clinical Trials as Topic; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Retinopathy; Disease Models, Animal; Drug Design; Glycation End Products, Advanced; Guanidines; Humans; Hydrazines; Hypoglycemic Agents; Thiadiazoles; Thiazoles; Thiazolidines | 2002 |
[Carbonyl stress inhibitor towards new therapeutic interventions in diabetic nephropathy].
Topics: Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Diabetes Mellitus; Diabetic Nephropathies; Glycation End Products, Advanced; Guanidines; Humans; Hydralazine; Hydrazines; Imidazoles; Olmesartan Medoxomil; Oxidative Stress; Pyridoxamine; Tetrazoles | 2004 |
Potential new therapeutic agents for diabetic kidney disease.
Topics: Amides; Animals; Clinical Trials as Topic; Connective Tissue Growth Factor; Diabetic Nephropathies; Disease Progression; Endothelin Receptor Antagonists; Glycation End Products, Advanced; Glycosaminoglycans; Guanidines; Humans; Hydrazines; Kidney; NADPH Oxidases; Nitric Oxide Synthase; Pentoxifylline; Phosphodiesterase Inhibitors; Pyridines; Pyridoxamine; Pyrimidines; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vitamin B Complex | 2010 |
1 other study(ies) available for pimagedine and alt-946
Article | Year |
---|---|
ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.
Topics: Amides; Animals; Animals, Genetically Modified; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Glomerular Filtration Rate; Glycation End Products, Advanced; Guanidines; Hydrazines; Immunohistochemistry; Kidney Cortex; Nitric Oxide Synthase; Organ Size; Rats; Rats, Mutant Strains | 2002 |